Clinical trial

Improving Care After Inherited Cancer Testing

NCT04763915

StatusACTIVE_NOT_RECRUITING

Study typeINTERVENTIONAL

Start date2022-08-05

PhaseNA

Study timeline

Study start (actual)2022-08-05Date precision: day

Registry last updated2025-09-19

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Inherited Cancer Syndromeverified · MONDO: hereditary neoplastic syndrome

Prostate Cancerverified · MONDO: prostate cancer

Colorectal Cancerverified · MONDO: colorectal cancer

Endometrial Cancerverified · MONDO: endometrial cancer

Breast Cancerverified · MONDO: breast cancer

Interventions

Correlative Studies (Survey)OTHER

Correlative Studies (Interview)OTHER

GeneSHAREBEHAVIORAL

LivingLabReportBEHAVIORAL

Standard-of-care & Adaptive InterventionBEHAVIORAL

Access to Education MaterialsOTHER

Sponsors & collaborators

Vanderbilt-Ingram Cancer Centerlead sponsor

National Cancer Institute (NCI)collaborator

University of South Floridacollaborator

Mapped research locations

NashvilleTennessee, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04763915 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.